Return to Care - Is COVID-19 a Heart Disease?

UCSF Education for Healthcare Providers on Care and Research During COVID-19
Course video and enrollment
Return to Care

Learn More

Course Videos

Planning Committee Disclosures

Overview and Learning Objectives

CME Credit

Cultural and Linguistic Competency

Want to see more like this? View additional CME offerings

Is COVID-19 a Heart Disease?

To begin the course, play the video below. There is a link below the video to complete the evaluation and post-test if you want to receive credit for this activity.

Starts On: 8/5/2020
Ends On: 8/4/2021
Session Type: Internet Activity Enduring Material
Course Number: MED23088Y
Credits: 1.25

For Credit, complete the evaluation and post-test

This activity was recorded on November 18, 2020.  This presentation is part of the Osher Mini Medical School for the Public: What’s Next: COVID-19, Science, and the Public Health webinar series. View previous and upcoming presentations at https://osherminimed.ucsf.edu/

Learning Objectives

  • Describe the damage inflicted by SARS-CoV-2 on heart cells
  • Describe the signs of cardiac dysfunction seen in patients with COVID-19

Faculty

Bruce Conklin, MD
Senior Investigator, Gladstone Institutes
Professor of Medicine, Cellular and Molecular Pharmacology, and Ophthalmology,
UC San Francisco
Deputy Director, Innovative Genomics Institute

Todd McDevitt, PhD
Senior Investigator, Gladstone Institutes
Professor of Bioengineering and Therapeutic Sciences, UC San Francisco
Program Director, Graduate Program in Bioengineering, UC San Francisco and UC Berkeley

Disclosure of Financial Relationships

Bruce Conklin, MD
Founder, Tenaya Therapeutics

Todd McDevitt, PhD
Co-founder and stock shareholder, CellectCell
Consultant and stock shareholder, Tenaya Therapeutics

Accreditation Information

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.   Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 credit™ from organizations accredited by the ACCME.

Pharmacy: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credits™.